This study investigates solid tumors that are Fibroblast Activation Protein (FAP)-positive. The purpose of this study is to evaluate an investigational therapy using a specific type of radiation for patients with these tumors.
The study is focused on exploring the safety and effectiveness of a targeted radiation therapy. It looks into how well the therapy works and how safe it is for patients with FAP-positive tumors.
- Who can participate: Adults aged 18 and older with a positive scan showing tumor uptake, and a solid tumor that is locally advanced or metastatic, may be eligible. Participants must have satisfactory organ function and a life expectancy of more than 3 months.
- Study details: Participants will receive an investigational medication that uses a type of radiation aimed at treating tumors.
How understandable was the trial content above?
Hard to understand
Easy to understand